120 related articles for article (PubMed ID: 33309749)
1. N-(Methyloxycarbonyl)thiophene sulfonamides as high affinity AT2 receptor ligands.
Wannberg J; Gising J; Lindman J; Salander J; Gutiérrez-de-Terán H; Ablahad H; Hamid S; Grönbladh A; Spizzo I; Gaspari TA; Widdop RE; Hallberg A; Backlund M; Leśniak A; Hallberg M; Larhed M
Bioorg Med Chem; 2021 Jan; 29():115859. PubMed ID: 33309749
[TBL] [Abstract][Full Text] [Related]
2. N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands.
Wannberg J; Gising J; Henriksson M; Vo DD; Sävmarker J; Sallander J; Gutiérrez-de-Terán H; Larsson J; Hamid S; Ablahad H; Spizzo I; Gaspari TA; Widdop RE; Grönbladh A; Petersen NN; Backlund M; Hallberg M; Larhed M
Eur J Med Chem; 2024 Feb; 265():116122. PubMed ID: 38199164
[TBL] [Abstract][Full Text] [Related]
3. A convenient transesterification method for synthesis of AT2 receptor ligands with improved stability in human liver microsomes.
Wannberg J; Isaksson R; Bremberg U; Backlund M; Sävmarker J; Hallberg M; Larhed M
Bioorg Med Chem Lett; 2018 Feb; 28(3):519-522. PubMed ID: 29279275
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds.
Gopalan G; Palo-Nieto C; Petersen NN; Hallberg M; Larhed M
Bioorg Med Chem; 2022 Jul; 65():116790. PubMed ID: 35550979
[TBL] [Abstract][Full Text] [Related]
5. 2-Alkyl substituted benzimidazoles as a new class of selective AT2 receptor ligands.
Roy T; Petersen NN; Gopalan G; Gising J; Hallberg M; Larhed M
Bioorg Med Chem; 2022 Jul; 66():116804. PubMed ID: 35576659
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin Peptides as AT2 Receptor Agonists.
Hallberg M; Sävmarker J; Hallberg A
Curr Protein Pept Sci; 2017; 18(8):809-818. PubMed ID: 28164758
[TBL] [Abstract][Full Text] [Related]
7. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
Wu X; Wan Y; Mahalingam AK; Murugaiah AM; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
J Med Chem; 2006 Nov; 49(24):7160-8. PubMed ID: 17125268
[TBL] [Abstract][Full Text] [Related]
8. A Series of Analogues to the AT
Isaksson R; Lindman J; Wannberg J; Sallander J; Backlund M; Baraldi D; Widdop R; Hallberg M; Åqvist J; Gutierrez de Teran H; Gising J; Larhed M
ChemistryOpen; 2019 Jan; 8(1):114-125. PubMed ID: 30697513
[TBL] [Abstract][Full Text] [Related]
9. Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.
Guimond MO; Wallinder C; Alterman M; Hallberg A; Gallo-Payet N
Eur J Pharmacol; 2013 Jan; 699(1-3):160-71. PubMed ID: 23211679
[TBL] [Abstract][Full Text] [Related]
10. Direct stimulation of angiotensin II type 2 receptor reduces nitric oxide production in lipopolysaccharide treated mouse macrophages.
Isaksson R; Casselbrant A; Elebring E; Hallberg M; Larhed M; Fändriks L
Eur J Pharmacol; 2020 Feb; 868():172855. PubMed ID: 31837306
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Brouwers S; Smolders I; Massie A; Dupont AG
Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
[TBL] [Abstract][Full Text] [Related]
12. From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.
Murugaiah AM; Wu X; Wallinder C; Mahalingam AK; Wan Y; Sköld C; Botros M; Guimond MO; Joshi A; Nyberg F; Gallo-Payet N; Hallberg A; Alterman M
J Med Chem; 2012 Mar; 55(5):2265-78. PubMed ID: 22248302
[TBL] [Abstract][Full Text] [Related]
13. Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.
Mahalingam AK; Wan Y; Murugaiah AM; Wallinder C; Wu X; Plouffe B; Botros M; Nyberg F; Hallberg A; Gallo-Payet N; Alterman M
Bioorg Med Chem; 2010 Jun; 18(12):4570-90. PubMed ID: 20493713
[TBL] [Abstract][Full Text] [Related]
14. Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides.
Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
J Med Chem; 1993 Dec; 36(26):4239-49. PubMed ID: 8277506
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice.
Schwengel K; Namsolleck P; Lucht K; Clausen BH; Lambertsen KL; Valero-Esquitino V; Thöne-Reineke C; Müller S; Widdop RE; Denton KM; Horiuchi M; Iwai M; Boato F; Dahlöf B; Hallberg A; Unger T; Steckelings UM
J Mol Med (Berl); 2016 Aug; 94(8):957-66. PubMed ID: 26983606
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule AT2 receptor agonists.
Hallberg M; Sumners C; Steckelings UM; Hallberg A
Med Res Rev; 2018 Mar; 38(2):602-624. PubMed ID: 28609561
[TBL] [Abstract][Full Text] [Related]
17. β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats.
Del Borgo M; Wang Y; Bosnyak S; Khan M; Walters P; Spizzo I; Perlmutter P; Hilliard L; Denton K; Aguilar MI; Widdop RE; Jones ES
Clin Sci (Lond); 2015 Sep; 129(6):505-13. PubMed ID: 26186568
[TBL] [Abstract][Full Text] [Related]
18. 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations.
Ivanova J; Balode A; Žalubovskis R; Leitans J; Kazaks A; Vullo D; Tars K; Supuran CT
Bioorg Med Chem; 2017 Feb; 25(3):857-863. PubMed ID: 28024887
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors.
Malmström J; Viklund J; Slivo C; Costa A; Maudet M; Sandelin C; Hiller G; Olsson LL; Aagaard A; Geschwindner S; Xue Y; Vasänge M
Bioorg Med Chem Lett; 2012 Sep; 22(18):5919-23. PubMed ID: 22889803
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.
Wan Y; Wallinder C; Plouffe B; Beaudry H; Mahalingam AK; Wu X; Johansson B; Holm M; Botoros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Gallo-Payet N; Hallberg A; Alterman M
J Med Chem; 2004 Nov; 47(24):5995-6008. PubMed ID: 15537354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
